DE68919982D1 - Ein Sulfydril enthaltendes Reduktionsmittel enthaltende stabilisierte Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Chlamydia und Gonokokken. - Google Patents

Ein Sulfydril enthaltendes Reduktionsmittel enthaltende stabilisierte Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Chlamydia und Gonokokken.

Info

Publication number
DE68919982D1
DE68919982D1 DE68919982T DE68919982T DE68919982D1 DE 68919982 D1 DE68919982 D1 DE 68919982D1 DE 68919982 T DE68919982 T DE 68919982T DE 68919982 T DE68919982 T DE 68919982T DE 68919982 D1 DE68919982 D1 DE 68919982D1
Authority
DE
Germany
Prior art keywords
sulfydril
gonococci
chlamydia
stabilized
determination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68919982T
Other languages
English (en)
Other versions
DE68919982T2 (de
Inventor
John C Mauck
Robert W Zercie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Application granted granted Critical
Publication of DE68919982D1 publication Critical patent/DE68919982D1/de
Publication of DE68919982T2 publication Critical patent/DE68919982T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE68919982T 1988-10-07 1989-09-29 Ein Sulfydril enthaltendes Reduktionsmittel enthaltende stabilisierte Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Chlamydia und Gonokokken. Expired - Fee Related DE68919982T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/255,921 US5075221A (en) 1988-10-07 1988-10-07 Stabilized extraction composition containing a sulfhydryl-containing reducing agent and its use in chlamydial and gonococcal determinations

Publications (2)

Publication Number Publication Date
DE68919982D1 true DE68919982D1 (de) 1995-01-26
DE68919982T2 DE68919982T2 (de) 1995-08-03

Family

ID=22970398

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68919982T Expired - Fee Related DE68919982T2 (de) 1988-10-07 1989-09-29 Ein Sulfydril enthaltendes Reduktionsmittel enthaltende stabilisierte Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Chlamydia und Gonokokken.

Country Status (4)

Country Link
US (1) US5075221A (de)
EP (1) EP0363105B1 (de)
JP (1) JPH0670631B2 (de)
DE (1) DE68919982T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460944A (en) * 1991-10-28 1995-10-24 Boehringer Mannheim Gmbh Storable protein solution
US5484706A (en) * 1993-05-19 1996-01-16 Pasteur Sanofi Diagnostics Immunoassay for analytes in samples using alkylating agents
JPH0716634U (ja) * 1993-08-31 1995-03-20 株式会社イトーキクレビオ はね上げテーブル
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
US5773234A (en) * 1995-08-07 1998-06-30 Quidel Corporation Method and device for chlamydia detection
US6589797B2 (en) * 2000-05-26 2003-07-08 The Research Foundation Of State University Of New York Recovery of liquids from absorbent packaging materials
US7008797B2 (en) * 2000-05-26 2006-03-07 The Research Foundation Of State University Of New York Recovery of liquids from absorbent packaging materials
WO2006066804A1 (de) * 2004-12-20 2006-06-29 Biotesys Gmbh In-vitro diagnostikum für analyten mit immunspezifischem nachweis
US8153529B2 (en) * 2009-11-20 2012-04-10 Eastman Kodak Company Method for selective deposition and devices
CN111965356B (zh) * 2019-11-28 2023-09-08 上海荣盛生物药业股份有限公司 巯基还原组合物及荧光微球层析试纸和应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860484A (en) * 1972-09-28 1975-01-14 Xerox Corp Enzyme stabilization
US4150950A (en) * 1977-09-28 1979-04-24 Corning Glass Works Transport system for clinical specimens
US4201694A (en) * 1978-07-17 1980-05-06 Beckman Instruments, Inc. Method for increasing shelf-life of a serum bilirubin reference composition and composition produced thereby
US4339533A (en) * 1980-07-30 1982-07-13 Technicon Instruments Corporation Stabilization of creatine kinase (CK) and its application as a reference standard
JPS5791910A (en) * 1980-11-28 1982-06-08 Kao Corp Preshampoo-type hair treatment composition
US4427782A (en) * 1981-03-03 1984-01-24 Caldwell Harlan D Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis
US4540565A (en) * 1981-08-13 1985-09-10 American Hospital Supply Corporation Reduced IgG in low ionic strength medium for immunohematologic agglutination
JPS5892622A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロン安定配合製剤
JPS58167520A (ja) * 1982-03-27 1983-10-03 Sunstar Inc インタ−フエロン安定配合製剤
US4497900A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Neisseria gonorrhoeae antigens
US4497899A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Chlamydia trachomatis antigens
JPS59182804A (ja) * 1983-04-01 1984-10-17 Toray Ind Inc 反応性微粒子およびその製造法
JPS59122952A (ja) * 1983-04-07 1984-07-16 ベツクマン・インスツルメンツ・インコ−ポレ−テツド 血清ビリルビン標準組成物の貯蔵寿命を伸ばす方法およびその生成組成物
JPS6090217A (ja) * 1983-10-24 1985-05-21 Dainippon Ink & Chem Inc 新設または修繕用エポキシ樹脂組成物およびそれを含んだ施工材料
GB8427006D0 (en) * 1984-10-25 1984-11-28 Iq Bio Ltd Determination of chlamydia trachomatis
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
JPS62177051A (ja) * 1986-01-30 1987-08-03 Mitsui Saianamitsudo Kk アクリルアミド系重合体水溶液の安定化法
JPH07726B2 (ja) * 1986-02-07 1995-01-11 三井サイテック株式会社 アクリルアミド系重合体水溶液の安定化法
US5155024A (en) * 1986-07-10 1992-10-13 Eastman Kodak Company Binder composition and analytical element having stabilized peroxidase in layer containing the composition
US4707450A (en) * 1986-09-25 1987-11-17 Nason Frederic L Specimen collection and test unit
DE3786388T2 (de) * 1986-10-16 1994-01-05 Abbott Lab Analytisches Gerät und Verfahren zum Nachweis von Chlamydia Trachomatis und Neisseria Gonorrhoeae.
JPS63145219A (ja) * 1986-12-09 1988-06-17 Kao Corp 加温式毛髪変形処理剤
US4833087A (en) * 1987-02-27 1989-05-23 Eastman Kodak Company Disposable container configured to produce uniform signal
US4828978A (en) * 1987-09-18 1989-05-09 Eastman Kodak Company Agglutination reagent and method of preparing same
US4859604A (en) * 1987-08-27 1989-08-22 Ampor, Inc. Composition for stabilization of diagnostic reagents
US4746614A (en) * 1987-09-18 1988-05-24 Eastman Kodak Company Extraction device
US4874691A (en) * 1987-10-16 1989-10-17 Quadra Logic Technologies Inc. Membrane-supported immunoassays

Also Published As

Publication number Publication date
DE68919982T2 (de) 1995-08-03
EP0363105A3 (de) 1991-07-17
US5075221A (en) 1991-12-24
EP0363105B1 (de) 1994-12-14
EP0363105A2 (de) 1990-04-11
JPH0670631B2 (ja) 1994-09-07
JPH02229861A (ja) 1990-09-12

Similar Documents

Publication Publication Date Title
NZ221935A (en) Composition for topical application containing a growth factor and/or other related materials
KR860002503A (ko) 트랜스-6-[2-알킬]-피란-2-온 및 그 제조방법
GB2275774B (en) Stabilized compositions containing troponin C and troponin I or tropinin T
DE3879468D1 (de) Fluorierte oligophenyle und ihre verwendung in fluessigkristallinen materialien.
DE69009822D1 (de) Zusammensetzung und ihre Verwendung.
HK1008037A1 (en) Polytetrafluoroethylene containing coating composition and use thereof
DE3784199D1 (de) Titanocene und deren verwendung.
DE3783627D1 (de) Lagerstabile heisshaertbare mischungen und deren verwendung.
DE3887787D1 (de) Eine Mikro-Emulsion enthaltende Zusammensetzung aus carboxylsubstituiertem Siloxan sowie deren Verwendung.
DE68924118D1 (de) Hoch-pH-Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Antigenen aus Chlamydia, Gonokokken oder Herpes.
IL95485A0 (en) Acridine derivatives,reagent compositions containing them and their use in the quantitative determination of reticulocytes in whole blood
MX9100801A (es) Pipeta y metodo para abrir la misma
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
GB2320589A8 (en) Improved stabilized and servocontrolled platform
DE68919982D1 (de) Ein Sulfydril enthaltendes Reduktionsmittel enthaltende stabilisierte Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Chlamydia und Gonokokken.
GR890100725A (en) Method for biological fiqhting against varroatose and dispo for its application
DE68916362D1 (de) Immunologische Reagenz-Zusammensetzung und deren Verwendung zur Bestimmung von chlamydialen oder gonokokkalen Antigenen.
DE68914912D1 (de) Flüssigkristallzusammensetzung und deren Verwendung.
DE3688864D1 (de) L-phenylalanindehydrogenase und deren verwendung.
PT87809A (pt) Promotoren zur expression von freemd-dna in methylotrophen bakterien deren gewinnung und deren verwendung
ATE90510T1 (de) Antimikrobische zusammensetzung und deren verwendung.
IL82840A0 (en) Method and compositions for the determination of occult blood
DE3766441D1 (de) Anilinotriazine und deren verwendung.
ATE86435T1 (de) Antimikrobische zusammensetzung und verfahren zu deren verwendung.
FR2598153B1 (fr) Composition emulsifiante et emulsion inverse la contenant

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC., ROCH

8328 Change in the person/name/address of the agent

Free format text: STREHL, SCHUEBEL-HOPF, GROENING & PARTNER, 80538 MUENCHEN

8339 Ceased/non-payment of the annual fee